OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
206059

National Industrialization Company SJSC

Commodity ChemicalsVerified

National Industrialization Company SJSC has a debt-to-equity ratio of 0.78 and a current ratio of 0.92, indicating moderate leverage and limited short-term liquidity cushion. The company's liquidity position is assessed as medium risk, with free cash flow of -SAR 1.37 billion and operating cash flow of -SAR 205.5 million in the latest period. The negative net cash position after subtracting total debt further highlights the company's liquidity constraints. The company's profitability metrics are weak, with a return on equity of -22.55% and a return on assets of -8.48%. These figures fall significantly below the industry median for commodity chemicals, which typically exhibit positive returns in stable market conditions. The operating loss of SAR 1.33 billion and net loss of SAR 1.77 billion underscore the company's current financial distress. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financial report. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes in Saudi Arabia. No material revenue contributions from international markets are reported. The company's growth trajectory is negative, with a net loss of SAR 1.77 billion and declining operating cash flow. Analysts have assigned a mean price target of SAR 9.86, with a median of SAR 9.70, and no strong buy recommendations. The absence of positive analyst sentiment and the company's current financial performance suggest a challenging outlook for the near term. The company's risk profile is elevated, with a liquidity risk and a key flag indicating negative net cash after debt. The dilution risk is assessed as low, with no recent signs of share issuance or dilution pressure. However, the company's negative free cash flow and operating cash flow may necessitate future financing, which could introduce dilution risk if not funded through asset sales or debt restructuring. No recent filings or transcripts have been disclosed that provide additional insight into the company's strategic direction or operational performance. The absence of recent public commentary or guidance suggests limited transparency into the company's near-term plans.

30-day price · 2060-0.25 (-2.5%)
Low$9.65High$10.80Close$9.90As of21 May, 00:00 UTC
Profile
CompanyNational Industrialization Company SJSC
Ticker2060.SE
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. National Industrialization Company SJSC is a Saudi Arabian chemicals company that produces and distributes commodity chemicals, primarily serving industrial and construction markets.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

National Industrialization Company SJSC has a debt-to-equity ratio of 0.78 and a current ratio of 0.92, indicating moderate leverage and limited short-term liquidity cushion. The company's liquidity position is assessed as medium risk, with free cash flow of -SAR 1.37 billion and operating cash flow of -SAR 205.5 million in the latest period. The negative net cash position after subtracting total debt further highlights the company's liquidity constraints. The company's profitability metrics are weak, with a return on equity of -22.55% and a return on assets of -8.48%. These figures fall significantly below the industry median for commodity chemicals, which typically exhibit positive returns in stable market conditions. The operating loss of SAR 1.33 billion and net loss of SAR 1.77 billion underscore the company's current financial distress. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification in the latest financial report. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes in Saudi Arabia. No material revenue contributions from international markets are reported. The company's growth trajectory is negative, with a net loss of SAR 1.77 billion and declining operating cash flow. Analysts have assigned a mean price target of SAR 9.86, with a median of SAR 9.70, and no strong buy recommendations. The absence of positive analyst sentiment and the company's current financial performance suggest a challenging outlook for the near term. The company's risk profile is elevated, with a liquidity risk and a key flag indicating negative net cash after debt. The dilution risk is assessed as low, with no recent signs of share issuance or dilution pressure. However, the company's negative free cash flow and operating cash flow may necessitate future financing, which could introduce dilution risk if not funded through asset sales or debt restructuring. No recent filings or transcripts have been disclosed that provide additional insight into the company's strategic direction or operational performance. The absence of recent public commentary or guidance suggests limited transparency into the company's near-term plans.
Key takeaways
  • The company is operating at a significant loss, with a net loss of SAR 1.77 billion and negative operating cash flow.
  • Liquidity is constrained, with a current ratio of 0.92 and negative net cash after debt.
  • Return on equity and return on assets are negative, indicating poor capital efficiency.
  • Revenue is concentrated in a single segment and geographic region, increasing exposure to local economic risks.
  • Analysts have assigned a neutral to bearish outlook, with no strong buy recommendations and a mean price target of SAR 9.86.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencySAR
Revenue$2.49B
Gross profit$85.4M
Operating income-$1.33B
Net income-$1.77B
R&D
SG&A
D&A
SBC
Operating cash flow-$205.5M
CapEx-$312.5M
Free cash flow-$1.37B
Total assets$20.82B
Total liabilities$12.99B
Total equity$7.83B
Cash & equivalents$1.87B
Long-term debt$6.08B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$2.49B-$1.33B-$1.77B-$1.37B
FY-1$3.02B-$321.0M-$27.9M-$210.8M
FY-2$3.57B$413.9M$201.6M$386.5M
FY-3$3.88B$1.32B$666.3M$1.17B
FY-4$3.67B$2.52B$1.36B$2.27B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$20.82B$7.83B$1.87B
FY-1$26.38B$9.65B$3.37B
FY-2$25.38B$9.65B$3.34B
FY-3$24.66B$9.61B$2.20B
FY-4$24.98B$8.70B$2.74B
PeriodOCFCapExFCFSBC
FY0-$205.5M-$312.5M-$1.37B
FY-1-$70.3M-$166.3M-$210.8M
FY-2$149.6M-$60.1M$386.5M
FY-3$804.0M-$144.2M$1.17B
FY-4$844.8M-$54.2M$2.27B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$495.0M-$430.4M-$341.3M-$466.6M
FQ-1-$2.46B-$1.99B-$2.41B
FQ-2$859.7M-$657.1M-$558.5M-$636.1M
FQ-3$808.9M-$47.2M-$65.8M-$59.4M
FQ-4$648.2M$1.86B$895.8M$1.76B
FQ-5$226.4M-$523.5M-$97.8M-$386.6M
FQ-6$1.03B$135.9M$89.0M$127.1M
FQ-7$1.01B$98.8M$52.8M$116.7M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$20.04B$7.49B$1.60B
FQ-1$20.82B$7.83B$1.87B
FQ-2$23.79B$9.97B$1.94B
FQ-3$24.71B$10.48B$2.08B
FQ-4$24.85B$10.48B$2.67B
FQ-5$26.38B$9.65B$3.37B
FQ-6$25.92B$9.70B$3.14B
FQ-7$25.06B$9.54B$2.79B
PeriodOCFCapExFCFSBC
FQ0-$8.8M-$33.1M-$466.6M
FQ-1-$205.5M-$312.5M-$2.41B
FQ-2-$275.1M-$264.7M-$636.1M
FQ-3-$33.2M-$224.4M-$59.4M
FQ-4-$117.4M-$143.1M$1.76B
FQ-5-$70.3M-$166.3M-$386.6M
FQ-6$13.8M-$124.5M$127.1M
FQ-7-$320.7M-$66.3M$116.7M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$7.83B
Net cash-$4.21B
Current ratio0.9
Debt/Equity0.8
ROA-8.5%
ROE-22.6%
Cash conversion12.0%
CapEx/Revenue-12.6%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric2060Activity
Op margin-53.5%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-70.9%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin3.4%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-12.6%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity78.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target9.86 SAR
Median price target9.70 SAR
High price target12.00 SAR
Low price target8.00 SAR
Mean recommendation3.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count1.00
Hold count3.00
Sell count1.00
Strong-sell count0.00
Mean EPS estimate-0.00 SAR
Last actual EPS0.51 SAR
Source: analysis-pipeline (hybrid)Generated: 2026-05-21 00:24 UTCJob: f720ad14